Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice

Journal of Biological Chemistry

Volumn 287, Issue 10, 2012, Pages 7345-7356

  Bonzo, Jessica A ^a   Ferry, Christina H ^a   Matsubara, Tsutomu ^a   Kim, Jung Hwan ^a   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT ANIMALS; ADULT MICE; AMINO ACID METABOLISM; APOPTOTIC ACTIVITY; BILE ACID; BLOOD COAGULATION; CELL CYCLE CONTROL; EFFECTOR GENES; GENE PROMOTER; GLUCONEOGENESIS; HEPATOCELLULAR CARCINOMA; HEPATOCYTE NUCLEAR FACTORS; HEPATOCYTES; KNOCK OUTS; LIVER TUMORS; METABOLIC ROLES; MICROARRAY EXPRESSIONS; MOUSE MODELS; PREMATURE DEATH; SERUM ALBUMIN; TARGET GENES; UP-REGULATION;

AMINO ACIDS; BODY FLUIDS; CELL DEATH; MAMMALS; METABOLISM; TRANSCRIPTION FACTORS;

GENE EXPRESSION REGULATION;

CRE RECOMBINASE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; OSTEOGENIC PROTEIN 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE TARGETING; GENETIC ASSOCIATION; HEPATOCYTE NUCLEAR FACTOR 4ALPHA GENE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PERP GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; FATTY LIVER; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTES; HEPATOMEGALY; LIVER NEOPLASMS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; ORGAN SPECIFICITY; PHOSPHOPROTEINS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MUS;

EID: 84863279150     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.334599     Document Type: Article

References (58)

1. Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., and Parkin, D. M. (2010) GLOBOCAN 2008, Version 1.2. Cancer incidence and mortality worldwide. IARC CancerBase No. 10. International Agency for Research on Cancer, Lyon, France
2. Howlader, N., Noone, A. M., Krapcho, M., Neyman, N., Aminou, R., Waldron, W., Altekruse, S. F., Kosary, C. L., Ruhl, J., Tatalovich, Z., Cho, H., Mariotto, A., Eisner, M. P., Lewis, D. R., Chen, H. S., Feuer, E. J., Cronin, K. A., and Edwards, B. K. (eds) (2011) SEER Cancer Statistics Review, 1975-2008, NCI, National Institutes of Health, Bethesda, MD, http://seer.cancer.gov/csr/ 1975-2008
3. Llovet, J. M., Burroughs, A., and Bruix, J. (2003) Hepatocellular carcinoma. Lancet 362, 1907-1917 (Pubitemid 37518510)
4. Shaw, J. J., and Shah, S. A. (2011) Rising incidence and demographics of hepatocellular carcinoma in the USA. What does it mean? Expert Rev. Gastroenterol. Hepatol. 5, 365-370
5. Wisely, G. B., Miller, A. B., Davis, R. G., Thornquest, A. D., Jr., Johnson, R., Spitzer, T., Sefler, A., Shearer, B., Moore, J. T., Miller, A. B., Willson, T. M., and Williams, S. P. (2002) Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure 10, 1225-1234 (Pubitemid 35254011)
6. Dhe-Paganon, S., Duda, K., Iwamoto, M., Chi, Y. I., and Shoelson, S. E. (2002) Crystal structure of the HNF4α ligand binding domain in complex with endogenous fatty acid ligand. J. Biol. Chem. 277, 37973-37976 (Pubitemid 35154647)
7. Sladek, F. M., Zhong, W. M., Lai, E., and Darnell, J. E. (1990) Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4, 2353-2365 (Pubitemid 120026268)
8. Yuan, X., Ta, T. C., Lin, M., Evans, J. R., Dong, Y., Bolotin, E., Sherman, M. A., Forman, B. M., and Sladek, F. M. (2009) Identification of an endogenous ligand bound to a native orphan nuclear receptor. PLoS ONE 4, e5609
9. Hayhurst, G. P., Lee, Y. H., Lambert, G., Ward, J. M., and Gonzalez, F. J. (2001) Hepatocyte nuclear factor 4α (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell. Biol. 21, 1393-1403 (Pubitemid 32114986)
10. Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., Menzel, S., Cox, N. J., Fajans, S. S., Signorini, S., Stoffel, M., and Bell, G. I. (1996) Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1) Nature 384, 458-460 (Pubitemid 26414661)
11. Battle, M. A., Konopka, G., Parviz, F., Gaggl, A. L., Yang, C., Sladek, F. M., and Duncan, S. A. (2006) Hepatocyte nuclear factor 4α orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc. Natl. Acad. Sci. U.S.A. 103, 8419-8424 (Pubitemid 43838470)
12. Parviz, F., Matullo, C., Garrison, W. D., Savatski, L., Adamson, J. W., Ning, G., Kaestner, K. H., Rossi, J. M., Zaret, K. S., and Duncan, S. A. (2003) Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesis. Nat. Genet. 34, 292-296 (Pubitemid 36792861)
13. Santangelo, L., Marchetti, A., Cicchini, C., Conigliaro, A., Conti, B., Mancone, C., Bonzo, J. A., Gonzalez, F. J., Alonzi, T., Amicone, L., and Tripodi, M. (2011) The stable repression of mesenchymal program is required for hepatocyte identity. A novel role for hepatocyte nuclear factor 4α. Hepatology 53, 2063-2074
14. Thiery, J. P., and Sleeman, J. P. (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7, 131-142 (Pubitemid 43278296)
15. Lazarevich, N. L., Shavochkina, D. A., Fleishman, D. I., Kustova, I. F., Morozova, O. V., Chuchuev, E. S., and Patyutko, Y. I. (2010) Deregulation of hepatocyte nuclear factor 4 (HNF4) as a marker of epithelial tumor progression. Exp. Oncol. 32, 167-171
16. Ning, B. F., Ding, J., Yin, C., Zhong, W., Wu, K., Zeng, X., Yang, W., Chen, Y. X., Zhang, J. P., Zhang, X., Wang, H. Y., and Xie, W. F. (2010) Hepatocyte nuclear factor 4 α suppresses the development of hepatocellular carcinoma. Cancer Res. 70, 7640-7651
17. Lazarevich, N. L., Cheremnova, O. A., Varga, E. V., Ovchinnikov, D. A., Kudrjavtseva, E. I., Morozova, O. V., Fleishman, D. I., Engelhardt, N. V., and Duncan, S. A. (2004) Progression of HCC in mice is associated with a down-regulation in the expression of hepatocyte nuclear factors. Hepatology 39, 1038-1047 (Pubitemid 38428943)
18. Kalkuhl, A., Kaestner, K., Buchmann, A., and Schwarz, M. (1996) Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumors. Carcinogenesis 17, 609-612 (Pubitemid 26085347)
19. Yin, C., Lin, Y., Zhang, X., Chen, Y. X., Zeng, X., Yue, H. Y., Hou, J. L., Deng, X., Zhang, J. P., Han, Z. G., and Xie, W. F. (2008) Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4α gene. Hepatology 48, 1528-1539
20. Chen, W. S., Manova, K., Weinstein, D. C., Duncan, S. A., Plump, A. S., Prezioso, V. R., Bachvarova, R. F., and Darnell, J. E. (1994) Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev. 8, 2466-2477 (Pubitemid 24323824)
21. Schuler, M., Dierich, A., Chambon, P., and Metzger, D. (2004) Efficient temporally controlled targeted somatic mutagenesis in hepatocytes of the mouse. Genesis 39, 167-172 (Pubitemid 39079514)
22. Qu, A., Taylor, M., Xue, X., Matsubara, T., Metzger, D., Chambon, P., Gonzalez, F. J., and Shah, Y. M. (2011) Hypoxia-inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis. Hepatology 54, 472-483
23. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45
24. Inoue, Y., Hayhurst, G. P., Inoue, J., Mori, M., and Gonzalez, F. J. (2002) Defective ureagenesis in mice carrying a liver-specific disruption of hepatocyte nuclear factor 4α (HNF4α). HNF4α regulates ornithine transcarbamylase in vivo. J. Biol. Chem. 277, 25257-25265 (Pubitemid 34951833)
25. Ladias, J. A., Hadzopoulou-Cladaras, M., Kardassis, D., Cardot, P., Cheng, J., Zannis, V., and Cladaras, C. (1992) Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. J. Biol. Chem. 267, 15849-15860
26. Mietus-Snyder, M., Sladek, F. M., Ginsburg, G. S., Kuo, C. F., Ladias, J. A., Darnell, J. E., Jr., and Karathanasis, S. K. (1992) Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. Mol. Cell. Biol. 12, 1708-1718
27. Stroup, D., and Chiang, J. Y. (2000) HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7α-hydroxylase gene (CYP7A1). J. Lipid Res. 41, 1-11 (Pubitemid 30051836)
28. Zhang, Y., Bonzo, J. A., Gonzalez, F. J., and Wang, L. (2011) Diurnal regulation of the early growth response 1 (Egr-1) protein expression by hepatocyte nuclear factor 4α (HNF4α) and small heterodimer partner (SHP) cross-talk in liver fibrosis. J. Biol. Chem. 286, 29635-29643
29. Alison, M. R., Islam, S., and Lim, S. (2009) Stem cells in liver regeneration, fibrosis and cancer. The good, the bad, and the ugly. J. Pathol. 217, 282-298
30. Riehle, K. J., Dan, Y. Y., Campbell, J. S., and Fausto, N. (2011) New concepts in liver regeneration. J. Gastroenterol. Hepatol. 26, 203-212
31. Huang, W., Ma, K., Zhang, J., Qatanani, M., Cuvillier, J., Liu, J., Dong, B., Huang, X., and Moore, D. D. (2006) Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 312, 233-236
32. Hatziapostolou, M., Polytarchou, C., Aggelidou, E., Drakaki, A., Poultsides, G. A., Jaeger, S. A., Ogata, H., Karin, M., Struhl, K., Hadzopoulou- Cladaras, M., and Iliopoulos, D. (2011) An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 147, 1233-1247
33. Nolten, L. A., Steenbergh, P. H., and Sussenbach, J. S. (1995) Hepatocyte nuclear factor 1 α activates promoter 1 of the human insulin-like growth factor I gene via two distinct binding sites. Mol. Endocrinol. 9, 1488-1499
34. Kuo, C. J., Conley, P. B., Chen, L., Sladek, F. M., Darnell, J. E., Jr., and Crabtree, G. R. (1992) A transcriptional hierarchy involved in mammalian cell-type specification. Nature 355, 457-461
35. Lee, Y. H., Sauer, B., and Gonzalez, F. J. (1998) Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1α knockout mouse. Mol. Cell. Biol. 18, 3059-3068 (Pubitemid 28183474)
36. Lu, J. W., Hsia, Y., Yang, W. Y., Lin, Y. I., Li, C. C., Tsai, T. F., Chang, K. W., Shieh, G. S., Tsai, S. F., Wang, H. D., and Yuh, C. H. (2012) Identification of the common regulators for hepatocellular carcinoma induced by hepatitis B virus X antigen in a mouse model. Carcinogenesis 33, 209-219
37. Wang, S., and Hirschberg, R. (2011) Y-box protein-1 is a transcriptional regulator of BMP7. J. Cell. Biochem. 112, 1130-1137
38. Torres-Padilla, M. E., Sladek, F. M., and Weiss, M. C. (2002) Developmentally regulated N-terminal variants of the nuclear receptor hepatocyte nuclear factor 4α mediate multiple interactions through coactivator and corepressor-histone deacetylase complexes. J. Biol. Chem. 277, 44677-44687 (Pubitemid 36159057)
39. Inoue, Y., Peters, L. L., Yim, S. H., Inoue, J., and Gonzalez, F. J. (2006) Role of hepatocyte nuclear factor 4α in control of blood coagulation factor gene expression. J. Mol. Med. 84, 334-344
40. Attardi, L. D., Reczek, E. E., Cosmas, C., Demicco, E. G., McCurrach, M. E., Lowe, S. W., and Jacks, T. (2000) PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev. 14, 704-718 (Pubitemid 30176824)
41. Reczek, E. E., Flores, E. R., Tsay, A. S., Attardi, L. D., and Jacks, T. (2003) Multiple response elements and differential p53 binding control Perp expression during apoptosis. Mol. Cancer Res. 1, 1048-1057 (Pubitemid 38044980)
42. Stanulovi, V. S., Kyrmizi, I., Kruithof-de Julio, M., Hoogenkamp, M., Vermeulen, J. L., Ruijter, J. M., Talianidis, I., Hakvoort, T. B., and Lamers, W. H. (2007) Hepatic HNF4α deficiency induces periportal expression of glutamine synthetase and other pericentral enzymes. Hepatology 45, 433-444 (Pubitemid 46374600)
43. Bolotin, E., Liao, H., Ta, T. C., Yang, C., Hwang-Verslues, W., Evans, J. R., Jiang, T., and Sladek, F. M. (2010) Integrated approach for the identification of human hepatocyte nuclear factor 4α target genes using protein binding microarrays. Hepatology 51, 642-653
44. Ihrie, R. A., Marques, M. R., Nguyen, B. T., Horner, J. S., Papazoglu, C., Bronson, R. T., Mills, A. A., and Attardi, L. D. (2005) Perp is a p63-regulated gene essential for epithelial integrity. Cell 120, 843-856 (Pubitemid 40568801)
45. Beaudry, V. G., Jiang, D., Dusek, R. L., Park, E. J., Knezevich, S., Ridd, K., Vogel, H., Bastian, B. C., and Attardi, L. D. (2010) Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis. PLoS Genet. 6, e1001168
46. Cazzalini, O., Scovassi, A. I., Savio, M., Stivala, L. A., and Prosperi, E. (2010) Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat. Res. 704, 12-20
47. Sherr, C. J., and Roberts, J. M. (1999) CDK inhibitors. Positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512 (Pubitemid 29297917)
48. Hwang-Verslues, W. W., and Sladek, F. M. (2008) Nuclear receptor hepatocyte nuclear factor 4α1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter. Mol. Endocrinol. 22, 78-90
49. Xu, H., He, J. H., Xiao, Z. D., Zhang, Q. Q., Chen, Y. Q., Zhou, H., and Qu, L. H. (2010) Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology 52, 1431-1442
50. Morrissey, C., Brown, L. G., Pitts, T. E., Vessella, R. L., and Corey, E. (2010) Bone morphogenetic protein 7 is expressed in prostate cancer metastases, and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment. Neoplasia 12, 192-205
51. Alarmo, E. L., Rauta, J., Kauraniemi, P., Karhu, R., Kuukasjärvi, T., and Kallioniemi, A. (2006) Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer. Genes Chromosomes Cancer 45, 411-419 (Pubitemid 43346773)
52. Rothhammer, T., Poser, I., Soncin, F., Bataille, F., Moser, M., and Bosserhoff, A. K. (2005) Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res. 65, 448-456
53. Masuda, H., Fukabori, Y., Nakano, K., Takezawa, Y., Suzuki, T., and Yamanaka, H. (2003) Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer. Prostate 54, 268-274 (Pubitemid 36228163)
54. Sugimoto, H., Yang, C., LeBleu, V. S., Soubasakos, M. A., Giraldo, M., Zeisberg, M., and Kalluri, R. (2007) BMP-7 functions as a novel hormone to facilitate liver regeneration. FASEB J. 21, 256-264 (Pubitemid 46052564)
55. Zeisberg, M., Yang, C., Martino, M., Duncan, M. B., Rieder, F., Tanjore, H., and Kalluri, R. (2007) Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282, 23337-23347 (Pubitemid 47311952)
56. Tacke, F., Gäbele, E., Bataille, F., Schwabe, R. F., Hellerbrand, C., Klebl, F., Straub, R. H., Luedde, T., Manns, M. P., Trautwein, C., Brenner, D. A., Schölmerich, J., and Schnabl, B. (2007) Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells. Dig. Dis. Sci. 52, 3404-3415 (Pubitemid 350077191)
57. Chayanupatkul, M., Honsawek, S., Vejchapipat, P., Chongsrisawat, V., and Poovorawan, Y. (2009) Elevated serum bone morphogenetic protein 7 levels and clinical outcome in children with biliary atresia. Eur. J. Pediatr. Surg. 19, 246-250
58. Fiaschetti, G., Castelletti, D., Zoller, S., Schramm, A., Schroeder, C., Nagaishi, M., Stearns, D., Mittelbronn, M., Eggert, A., Westermann, F., Ohgaki, H., Shalaby, T., Pruschy, M., Arcaro, A., and Grotzer, M. A. (2011) Bone morphogenetic protein-7 is aMYCtarget with prosurvival functions in childhood medulloblastoma. Oncogene 30, 2823-2835